Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 238


UL40-mediated NK evasion during productive infection with human cytomegalovirus.

Wang EC, McSharry B, Retiere C, Tomasec P, Williams S, Borysiewicz LK, Braud VM, Wilkinson GW.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7570-5.


Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity.

Cerboni C, Mousavi-Jazi M, Wakiguchi H, Carbone E, Kärre K, Söderström K.

Eur J Immunol. 2001 Oct;31(10):2926-35.


Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.

Gumá M, Budt M, Sáez A, Brckalo T, Hengel H, Angulo A, López-Botet M.

Blood. 2006 May 1;107(9):3624-31. Epub 2005 Dec 29.


NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies.

Magri G, Muntasell A, Romo N, Sáez-Borderías A, Pende D, Geraghty DE, Hengel H, Angulo A, Moretta A, López-Botet M.

Blood. 2011 Jan 20;117(3):848-56. doi: 10.1182/blood-2010-08-301374. Epub 2010 Oct 28.


Renal carcinoma cell lines inhibit natural killer activity via the CD94 receptor molecule.

Stanley AJ, Gough MJ, Banks RE, Selby PJ, Patel PM.

Cancer Immunol Immunother. 2001 Jul;50(5):260-8.


Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.

Gumá M, Angulo A, Vilches C, Gómez-Lozano N, Malats N, López-Botet M.

Blood. 2004 Dec 1;104(12):3664-71. Epub 2004 Aug 10.


The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.

Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A.

Eur J Immunol. 2003 Jun;33(6):1657-66. Erratum in: Eur J Immunol. 2003 Oct;33(10):2947.


Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.

Heatley SL, Pietra G, Lin J, Widjaja JM, Harpur CM, Lester S, Rossjohn J, Szer J, Schwarer A, Bradstock K, Bardy PG, Mingari MC, Moretta L, Sullivan LC, Brooks AG.

J Biol Chem. 2013 Mar 22;288(12):8679-90. doi: 10.1074/jbc.M112.409672. Epub 2013 Jan 18.


Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.

Rölle A, Mousavi-Jazi M, Eriksson M, Odeberg J, Söderberg-Nauclér C, Cosman D, Kärre K, Cerboni C.

J Immunol. 2003 Jul 15;171(2):902-8.


Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.

López-Botet M, Angulo A, Gumá M.

Tissue Antigens. 2004 Mar;63(3):195-203. Review.


Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children.

Monsiváis-Urenda A, Noyola-Cherpitel D, Hernández-Salinas A, García-Sepúlveda C, Romo N, Baranda L, López-Botet M, González-Amaro R.

Eur J Immunol. 2010 May;40(5):1418-27. doi: 10.1002/eji.200939898. Erratum in: Eur J Immunol. 2011 Jan;41(1):258.


Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis.

Ulbrecht M, Martinozzi S, Grzeschik M, Hengel H, Ellwart JW, Pla M, Weiss EH.

J Immunol. 2000 May 15;164(10):5019-22.


NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation.

Falk CS, Mach M, Schendel DJ, Weiss EH, Hilgert I, Hahn G.

J Immunol. 2002 Sep 15;169(6):3257-66.


HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity.

Cederarv M, Söderberg-Nauclér C, Odeberg J.

Immunobiology. 2009;214(5):331-41. doi: 10.1016/j.imbio.2008.10.009. Epub 2009 Jan 18.


Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.

Jinushi M, Takehara T, Tatsumi T, Kanto T, Miyagi T, Suzuki T, Kanazawa Y, Hiramatsu N, Hayashi N.

J Immunol. 2004 Nov 15;173(10):6072-81.


Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, Gadola S, Cerundolo V, Borysiewicz LK, McMichael AJ, Wilkinson GW.

Science. 2000 Feb 11;287(5455):1031.


Human leukocyte antigen E in human cytomegalovirus infection: friend or foe?

Gong F, Song S, Lv G, Pan Y, Zhang D, Jiang H.

Acta Biochim Biophys Sin (Shanghai). 2012 Jul;44(7):551-4. doi: 10.1093/abbs/gms032. Epub 2012 May 9. Review.


Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy.

Norris S, Doherty DG, Curry M, McEntee G, Traynor O, Hegarty JE, O'Farrelly C.

Cancer Immunol Immunother. 2003 Jan;52(1):53-8. Epub 2002 Dec 10.


Supplemental Content

Support Center